Pilot study: Dystrophyc pathways in human hair follicles after chemotherapy with or without scalp cooling.

Pilot study: Dystrophyc pathways in human hair follicles after chemotherapy with or without scalp cooling. - PATH-2

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON45664

Enrollment

Registered

2018-01-05

Start date

2017-03-16

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alopecia Hair loss

Interventions

chemotherapy

Dystrophic pathway

Hair follicle

Scalp Cooling

Eligibility

Age

18 Years to 64 Years

Inclusion criteria

Inclusion criteria: - Patients with cancer - Indication for at least one cycle docetaxel or paclitaxel - Age 18 years or more - Written informed consent

Exclusion criteria

Exclusion criteria: NA

Design outcomes

Primary

Measure	Time frame
The expression of apoptotic markers in the dystrophic pathway involved in chemotherapy induced alopecia.	—

Secondary

Measure	Time frame
Differences in the dystrophic pathway in patients with and without scalp cooling.	—

Countries

The Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)